Hedging gains boost MetLife earnings

MetLife was well-shielded against the stock market swoon at the end of 2018 by its hedging derivatives, which boosted fourth-quarter income to $2 billion, double that reported for the three months to end-September. 

Net derivatives gains for the fourth quarter were $939 million, reversing a net loss of $378 million posted in the third quarter. The late surge in the hedge portfolio's value led to a full-year net derivatives gain of $851 million, compared with a net loss of $590 million the year

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: